Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 7;36(46):3227-37.
doi: 10.1093/eurheartj/ehv162. Epub 2015 Jul 27.

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement

Domenico Corrado  1 , Thomas Wichter  2 , Mark S Link  3 , Richard Hauer  4 , Frank Marchlinski  5 , Aris Anastasakis  6 , Barbara Bauce  7 , Cristina Basso  7 , Corinna Brunckhorst  8 , Adalena Tsatsopoulou  9 , Harikrishna Tandri  10 , Matthias Paul  11 , Christian Schmied  8 , Antonio Pelliccia  12 , Firat Duru  8 , Nikos Protonotarios  9 , N A Mark Estes 3rd  3 , William J McKenna  13 , Gaetano Thiene  7 , Frank I Marcus  14 , Hugh Calkins  10
Affiliations
Review

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement

Domenico Corrado et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of risk stratification and indications to ICD implantation in ARVC/D. Based on the available data on annual mortality rates associated to specific risk factors, the estimated risk of major arrhythmic events in the high-risk category is >10%/year, in the intermediate ranges from 1 to 10%/year, and in the low-risk category is <1%/year. Indications to ICD implantation were determined by consensus taking into account not only the statistical risk, but also the general health, socioeconomic factors, the psychological impact and the adverse effects of the device. SCD, sudden cardiac death; VF, ventricular fibrillation; VT, ventricular tachycardia; RV, right ventricle; LV, left ventricle. *See the text for distinction between major and minor risk factors.
See this image and copyright information in PMC

References

    1. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982;65:384–398. - PubMed
    1. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129–133. - PubMed
    1. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 1996;94:983–991. - PubMed
    1. Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997;30:1512–1520. - PubMed
    1. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000;83:588–595. - PMC - PubMed

Publication types

MeSH terms

Substances